Suppr超能文献

母体和生命早期接触邻苯二甲酸酯:妊娠期间使用的塑料和个人护理产品(P4 研究)。

Maternal and early life exposure to phthalates: The Plastics and Personal-care Products use in Pregnancy (P4) study.

机构信息

Population Studies Division, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada.

Population Studies Division, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada.

出版信息

Sci Total Environ. 2016 May 1;551-552:344-56. doi: 10.1016/j.scitotenv.2016.02.022. Epub 2016 Feb 13.

Abstract

Phthalates are a group of chemicals found in a number of consumer products; some of these phthalates have been shown to possess estrogenic activity and display anti-androgenic effects. While a number of biomonitoring studies of phthalates in pregnant women and infants have been published, there is a paucity of data based on both multiple sampling periods and in different matrices. Phthalate metabolites were measured in 80 pregnant women and their infants in Ottawa Canada (2009-2010) in urine, meconium and breast milk collected at various time periods pre- and post-parturition. At least 50% of the women had at least one urine sample greater than the limit of detection (LOD) for the various phthalate metabolites, with the exception of mono-n-octyl phthalate (MnOP), mono-isononyl phthalate (MiNP) and mono(carboxy-isooctyl) phthalate (MCiOP). Four major clusters of maternal urinary metabolites were identified. Among infants (n=61), the following metabolites were rarely (< 10%) detected: mono-cyclohexyl phthalate (MCHP), mono-isononyl phthalate (MiNP), mono-methyl phthalate (MMP), and mono-n-octyl phthalate (MnOP). While mono-benzyl phthalate (MBzP), mono-3-carboxypropyl phthalate (MCPP), MEHHP, and MEOHP were frequently detected in maternal urines at any time point, these metabolites were rarely detected in breast milk. Maternal urinary concentrations of MEP and the DEHP metabolites were higher in samples collected during pregnancy than postnatally. No statistically significant differences were observed in infant's urinary phthalate concentrations between breast-fed and bottle-fed infants. Significant correlations were observed between maternal urinary MEHHP (r=0.35), MEOHP (r=0.35) and MEP (r=0.37) collected at <20weeks gestation with levels in meconium and between MBzP (r=0.78) and MEP (r=0.56) in maternal and infant urine collected 2-3months after birth. These results suggest at least some maternal-fetal-infant transfer of phthalates and that meconium may be a useful matrix for measuring in utero exposure to phthalates.

摘要

邻苯二甲酸酯是一组存在于许多消费产品中的化学物质;其中一些邻苯二甲酸酯已被证明具有雌激素活性,并表现出抗雄激素作用。虽然已经发表了许多关于孕妇和婴儿体内邻苯二甲酸酯的生物监测研究,但基于多个采样期和不同基质的数据仍然很少。在加拿大渥太华,对 80 名孕妇及其婴儿(2009-2010 年)进行了研究,在妊娠前后的不同时间点收集了尿液、胎粪和母乳,并检测了其中的邻苯二甲酸酯代谢物。至少有 50%的女性至少有一份尿液样本的各种邻苯二甲酸酯代谢物浓度超过检测限(LOD),除了单-正辛基邻苯二甲酸酯(MnOP)、单-异壬基邻苯二甲酸酯(MiNP)和单(羧基异辛基)邻苯二甲酸酯(MCiOP)。确定了四个主要的母体尿液代谢物群。在婴儿(n=61)中,很少(<10%)检测到以下代谢物:单环己基邻苯二甲酸酯(MCHP)、单异壬基邻苯二甲酸酯(MiNP)、单甲基邻苯二甲酸酯(MMP)和单正辛基邻苯二甲酸酯(MnOP)。尽管单苄基邻苯二甲酸酯(MBzP)、单-3-羧基丙基邻苯二甲酸酯(MCPP)、MEHHP 和 MEOHP 在任何时间点的母体尿液中都经常被检测到,但在母乳中很少被检测到。母尿中 MEP 和 DEHP 代谢物的浓度在妊娠期间采集的样本中高于产后。母乳喂养和奶瓶喂养的婴儿尿液中邻苯二甲酸酯浓度无统计学差异。在妊娠<20 周时采集的母体尿液中 MEHHP(r=0.35)、MEOHP(r=0.35)和 MEP(r=0.37)与胎粪中的水平以及出生后 2-3 个月时母尿和婴儿尿中 MBzP(r=0.78)和 MEP(r=0.56)之间存在显著相关性。这些结果表明,至少有一些母体-胎儿-婴儿的邻苯二甲酸酯转移,胎粪可能是测量体内邻苯二甲酸酯暴露的有用基质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验